对评审员的确认

IF 2.6 4区医学 Q3 CLINICAL NEUROLOGY

Neurodegenerative Diseases Pub Date : 2021-11-01 DOI:10.1159/000519810

{"title":"对评审员的确认","authors":"","doi":"10.1159/000519810","DOIUrl":null,"url":null,"abstract":"© 2021 S. Karger AG, Basel karger@karger.com www.karger.com/ndd Karger Publishers and the editors of Neurodegenerative Diseases would like to thank the reviewers for the ongoing support in reviewing manuscripts for our Journal in 2021. This year we have chosen not to disclose the names of our reviewers to preserve the principle of anonymity inherent to the single-blind peer-review we follow. Even so, this should not be in our way to sincerely thank all contributing reviewers who have volunteered their time, effort, and expertise in benefit of the quality of the manuscripts we received and published in 2021. Individual reviewers can still claim their personal “Certificate of Review” via the Journal’s manuscript submission system.","PeriodicalId":19115,"journal":{"name":"Neurodegenerative Diseases","volume":"20 1","pages":"217 - 217"},"PeriodicalIF":2.6000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Acknowledgement to Reviewers\",\"authors\":\"\",\"doi\":\"10.1159/000519810\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"© 2021 S. Karger AG, Basel karger@karger.com www.karger.com/ndd Karger Publishers and the editors of Neurodegenerative Diseases would like to thank the reviewers for the ongoing support in reviewing manuscripts for our Journal in 2021. This year we have chosen not to disclose the names of our reviewers to preserve the principle of anonymity inherent to the single-blind peer-review we follow. Even so, this should not be in our way to sincerely thank all contributing reviewers who have volunteered their time, effort, and expertise in benefit of the quality of the manuscripts we received and published in 2021. Individual reviewers can still claim their personal “Certificate of Review” via the Journal’s manuscript submission system.\",\"PeriodicalId\":19115,\"journal\":{\"name\":\"Neurodegenerative Diseases\",\"volume\":\"20 1\",\"pages\":\"217 - 217\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2021-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurodegenerative Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000519810\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurodegenerative Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000519810","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

摘要

©2021 S.Karger AG，巴塞尔karger@karger.comwww.karger.com/ndd-karger出版社和《神经退行性疾病》杂志的编辑们要感谢审稿人在2021年为我们的期刊审稿时给予的持续支持。今年，我们选择不披露审查人员的姓名，以保持我们所遵循的单一盲同行审查固有的匿名原则。即便如此，这也不应妨碍我们真诚地感谢所有贡献时间、精力和专业知识的审稿人，他们为我们在2021年收到并发表的稿件的质量而贡献了自己的时间、努力和专业知识。个人审稿人仍然可以通过《华尔街日报》的稿件提交系统申请他们的个人“审稿证书”。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Acknowledgement to Reviewers

© 2021 S. Karger AG, Basel karger@karger.com www.karger.com/ndd Karger Publishers and the editors of Neurodegenerative Diseases would like to thank the reviewers for the ongoing support in reviewing manuscripts for our Journal in 2021. This year we have chosen not to disclose the names of our reviewers to preserve the principle of anonymity inherent to the single-blind peer-review we follow. Even so, this should not be in our way to sincerely thank all contributing reviewers who have volunteered their time, effort, and expertise in benefit of the quality of the manuscripts we received and published in 2021. Individual reviewers can still claim their personal “Certificate of Review” via the Journal’s manuscript submission system.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Neurodegenerative Diseases 医学-临床神经学

CiteScore

5.90

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： ''Neurodegenerative Diseases'' is a bimonthly, multidisciplinary journal for the publication of advances in the understanding of neurodegenerative diseases, including Alzheimer''s disease, Parkinson''s disease, amyotrophic lateral sclerosis, Huntington''s disease and related neurological and psychiatric disorders.